City Cardiology Center 1
1. Unacceptably high mortality and readmission rates 5 years after heart failure hospitalization: The need to optimize long-term heart failure care by addressing diverse healthcare resources
2. Understanding the Role of Glucagon-like Peptide-1 Receptor Agonists in the Treatment of Heart Failure
3. Sex-Specific Trends and Predictors of Outcomes in Acute Myocardial Infarction in Almaty, Kazakhstan
4. Heart failure with preserved ejection fraction in cancer patients and survivors. A scientific statement of the Heart Failure Association of the ESC and the ESC Council of Cardio-Oncology
5. Global epidemiology of heart failure
6. 2023 Updated European Society of Cardiology guidelines on heart failure
7. Heart Failure With Preserved Ejection Fraction and Frailty: From Young to Superaged Coexisting HFpEF and Frailty
8. Prevention of cancer therapy-related cardiac dysfunction and heart failure in cancer patients and survivors. A Clinical Consensus Statement of the Heart Failure Association, the European Association of Preventive Cardiology of the ESC, and the ESC Council of Cardio-Oncology
9. Quality of life in heart failure and implantable cardioverter defibrillator patients: time to close the gap in holistic care
10. The Role of Sodium Zirconium Cyclosilicate in Optimizing Heart Failure Therapy
11. How to tackle therapeutic inertia in heart failure with reduced ejection fraction. A scientific statement of the Heart Failure Association of the ESC
12. Insights into the European heart failure epidemiology
13. The European heart failure management resources, treatment reimbursement and activities of professional and patient organizations
14. Profiling hypotension in heart failure based on office, orthostatic and ambulatory blood pressure measurements
1